Results 41 to 50 of about 33,588 (309)
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez+5 more
wiley +1 more source
TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam+10 more
wiley +1 more source
Background Lymphatic metastasis is the major challenge in the treatment of penile cancer. The prognosis of individuals with lymphatic metastasis is extremely poor.
Da‐Ming Xu+6 more
doaj +1 more source
PENILE CANCER AND OUR EXPERIENCE AT TERTIARY CARE HOSPITAL
Purpose: Penile cancer is a rare malignancy which accounts for
M Fahd Shah+5 more
doaj +1 more source
Importance of HPV in Chinese Penile Cancer: A Contemporary Multicenter Study
Objective: To investigate the HPV DNA prevalence and genotype distribution among penile cancer in China. To identify association between HPV prevalence, different histological subtypes, tumor stage, tumor grade, demographics, comorbidity, and phimosis ...
Weijie Gu+17 more
doaj +1 more source
Mortality and sexuality after diagnosis of penile cancer: A participative study [PDF]
Objectives: Survival for penile cancer is high but treatment can have a long-term detrimental effect on urological function and quality of life. Due to its rarity, it is difficult to include men with penile cancer in research about their condition.
Branney, P+5 more
core +1 more source
An update on treatment of penile cancer
Penile cancer is a rare malignancy, particularly in industrialized nations. In the United States, rates are approximately less than 1 per 100,000 men per year with just over 2000 new cases per year. However, there is significantly increased prevalence in developing nations, with limited treatment expertise and reduced access to care, further driving ...
Juskaran Chadha+2 more
openaire +3 more sources
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham+21 more
wiley +1 more source
Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)
In 2020, there were approximately 50,865 anal cancer cases and 36,068 penile cancer cases worldwide. HPV is considered the main causal agent for the development of anal cancer and one of the causal agents responsible for the development of penile cancer.
Victor Fernandez-Alonso+4 more
doaj +1 more source
Conservative management for postprostatectomy urinary incontinence [PDF]
BACKGROUND: Urinary incontinence is common after radical prostatectomy and can also occur in some circumstances after transurethral resection of the prostate (TURP).
Abbinante+177 more
core +1 more source